Biotech

All Articles

Kairos goes social with $6M IPO to finance trials of cancer medication

.Along with a trio of biotechs striking the Nasdaq on Friday, it was actually easy to miss a smaller...

Vaccine and Keytruda combination effective in squamous cell carcinoma

.Invulnerable gate preventions are actually the superheroes of cancer treatment. Medicines like Bris...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of significant management hirings, shootings ...

Regeneron's Opdualag competitor shows 57% feedback rate

.Regeneron is back with lasting consequence for its LAG-3 prevention and also PD-1 inhibitor combo i...

AstraZeneca blog posts information on internal opponents to AbbVie, Pfizer ADCs

.AstraZeneca has shared a very early examine the efficiency of its own internal antibody-drug conjug...

iTeos- GSK's TIGIT superstar shows meaningful improvement

.After introducing a stage 3 launch based upon beneficial midstage end results, iTeos and also GSK a...

More collaborative FDA may accelerate rare health condition R&ampD: report

.The FDA needs to be extra open and also joint to release a rise in commendations of unusual disease...

Zenas, MBX, Bicara head to Nasdaq in warm time for biotech IPOs

.It is actually an unusually hectic Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bica...

Atea's COVID antiviral falls short to stop hospital stays in period 3

.Atea Pharmaceuticals' antiviral has actually fallen short an additional COVID-19 trial, yet the bio...

Neurocrine's quote to save schizophrenia prospect fails

.Neurocrine Biosciences' schizophrenia course pivot has neglected. The biotech was not able to repli...